A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2002
11/27/2002	CN1382130A Substituted benzylthiazolidine-2,4-dione derivatives
11/27/2002	CN1382129A Substituted benzylthiazolidine-2,4-dione derivatives
11/27/2002	CN1382128A Substituted benzylthiazolidine-2,4-dione derivatives
11/27/2002	CN1382124A Bicycle androgen and progesterone receptor modulator compounds and methods
11/27/2002	CN1382122A Pyrrole derivatives as phosphodiesterase VII inhibitors
11/27/2002	CN1382120A Method of producing n-(4,5-bis-(methanesulfonyl)-2-methyl-benzoyl)-guanidine, hydrochloride thereof
11/27/2002	CN1382119A Substituted alpha hydroxy acid aspertate specific cysteine protease inhibitors and use thereof
11/27/2002	CN1382118A Biocyclic amino acids aspharmaceutical agents
11/27/2002	CN1382061A Pharmaceutical compositions for oral and topical administration
11/27/2002	CN1382060A Dosages for treatment with anti-ErbB2 antibodies
11/27/2002	CN1382055A Remedies
11/27/2002	CN1382052A Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders
11/27/2002	CN1382050A Oral formulations for anti-tumor compounds
11/27/2002	CN1382047A Neurotherapeutic clavulanate composition and method
11/27/2002	CN1382042A Treatment of emphysema using RAR selective retinoid agonists
11/27/2002	CN1382036A Solubilized pharmaceutical composition for parenteral administration
11/27/2002	CN1382022A Method for treatment of chronic venous insufficiencies using extract of red vine leaves
11/27/2002	CN1381456A Pyrimidine-4-keto compound, its preparation method and medicine composition containing them
11/27/2002	CN1381252A Chines medicine for treating silicosis
11/27/2002	CN1381244A Plaster for treating mastitis, scrofula, nail-like deep-rooted boil and sore and its preparing process
11/27/2002	CN1381234A Application of toosendanin as inducer to make differentiation and death of tumor cells
11/27/2002	CN1381202A Microbial breast-rounding beverage prepared by microalternative bioelectric field
11/27/2002	CN1094943C Urethanes and ureas that induce cytokine production
11/27/2002	CN1094937C Farnesyltransferase inhibiting quinazolinones
11/27/2002	CN1094936C New flavnoe compounds, process for preparing them and pharmaceutical compositions containing them
11/27/2002	CN1094763C Traditional Chinese medicinal pill for treating fatigue and tonifying kidney and brain
11/27/2002	CN1094759C Devitalization method for bone-matrix gelatin carrier
11/27/2002	CN1094758C Modulation of calcium channels
11/27/2002	CN1094754C Cell renewal rate compositions
11/26/2002	US6486326 iso-CBI and iso-CI analogs of CC-1065 duocarmycins
11/26/2002	US6486322 Azaindole derivatives, process for their preparation, and their use as antitumor agents
11/26/2002	US6486321 Epoxidation; quaternization
11/26/2002	US6486305 Method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
11/26/2002	US6486299 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
11/26/2002	US6486210 Such as enantiomorphs of 4-fluorostyryl-2,3,4,5,6-pentafluorobenzylsulfone; antiproliferative/anticancer agents
11/26/2002	US6486209 Use for 1,3-propanediol derivatives
11/26/2002	US6486192 Indole compounds useful for treating bacterial infections
11/26/2002	US6486190 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
11/26/2002	US6486189 Five-membered heterocycles having biphenylsulfonyl substitution, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
11/26/2002	US6486188 Method of treatment for cardiovascular complications
11/26/2002	US6486187 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines
11/26/2002	US6486186 Thiazole compounds as cyclic AMP-specific phosphodiesterase inhibitors and method of using the same
11/26/2002	US6486184 1-(cyclopentyloxy-(3,4-dichloro- phenyl)-acetyl)-3-methyl-urea for example; use in treating hyperglycemia characteristic of all type ii diabetes
11/26/2002	US6486156 Chemical compounds
11/26/2002	US6486154 (Hetero) aryl-sulfonamide derivatives, their preparation and their use as factor XA inhibitors
11/26/2002	US6486151 N-oxides of heterocyclic esters, amides, thioesters, and ketones
11/26/2002	US6486147 Cosmetic composition containing a steroid and a 2-alkylalkanol or an ester thereof
11/26/2002	US6486145 Meiosis regulating compounds
11/26/2002	US6486142 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
11/26/2002	US6486141 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
11/26/2002	US6486129 Antithrombotic compounds
11/26/2002	US6486125 Synthesis of soluble β-sheet forming peptides
11/26/2002	US6486122 Methods of increasing body weight in a subject by administering TGF-α
11/26/2002	US6485957 DNA encoding the human serine protease EOS
11/26/2002	US6485935 Structure of the ankyrin binding domain of a α-Na, K-ATPase
11/26/2002	US6485934 Regulatory system for inducible expression of genes with lambdoid promoters
11/26/2002	US6485932 Composition comprising immunoglobulin
11/26/2002	US6485929 Method for inhibiting CD95-independent apoptosis in AIDS
11/26/2002	US6485919 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof
11/26/2002	US6485727 Method for treatment of chronic venous insufficiencies using an extract of red vine leaves
11/26/2002	US6485724 Immortalized human keratinocyte cell line
11/26/2002	US6485704 Azo compound for type I pototherapy
11/26/2002	CA2258285C Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors
11/26/2002	CA2257142C 5-phenyl-3-pyridazinone derivatives and drug compositions containing the same
11/26/2002	CA2246482C Novel trans-3,4,4a,5,6,10b-hexahydro-2h-naphth¢1,2-b!-1,4-oxazines disubstitutes, process for preparing them and pharmaceutical compounds containing them
11/26/2002	CA2231364C Novel n-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands
11/26/2002	CA2228635C Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/26/2002	CA2111573C Cadherin materials and methods
11/26/2002	CA2078555C Novel vitamin d analogues
11/26/2002	CA2066913C Novel binding peptides
11/24/2002	CA2387007A1 Therapies for tissue damage resulting from ischemia
11/23/2002	CA2386740A1 Combination treatment for alcoholism and alcohol dependence
11/22/2002	WO2003101942A1 Amidine substituted aryl and heteroaryl derivatives with an antithrombotic and factor xa inhibiting action
11/22/2002	WO2001090079A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
11/22/2002	CA2445571A1 Substituted aryl and heteroaryl derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
11/22/2002	CA2410304A1 Novel carbamates and ureas production and use thereof as endothelin receptor antagonists
11/21/2002	WO2002092849A2 Methods
11/21/2002	WO2002092841A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002	WO2002092832A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
11/21/2002	WO2002092826A2 Composition and method for treating cancer using herpes virus
11/21/2002	WO2002092825A2 Retroviral vectors for gene therapy
11/21/2002	WO2002092817A1 Functions for d52 and ra006 nucleic acids and polypeptides
11/21/2002	WO2002092808A1 Random gene unidirectional antisense library
11/21/2002	WO2002092807A1 Unigene unidirectional antisense library
11/21/2002	WO2002092762A2 Cytokine polypeptides
11/21/2002	WO2002092759A2 Molecules for disease detection and treatment
11/21/2002	WO2002092758A2 Gastrokines and derived peptides including inhibitors
11/21/2002	WO2002092622A2 Dipeptide derivatives having a n-terminal 2-thioacyl group as vasopeptidase inhibitors
11/21/2002	WO2002092617A1 Combined approach to treatment of cancer using a c-myc antisense oligomer
11/21/2002	WO2002092606A1 Fused imidazolidine derivatives, process for preparation of the same and use thereof
11/21/2002	WO2002092604A1 1-oxa-3,9-diaza-spiro'5,5!undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor
11/21/2002	WO2002092603A1 Oxazolo-and furopyrimidines and their use in medicaments against tumors
11/21/2002	WO2002092599A1 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d) pyrimidine derivatives
11/21/2002	WO2002092595A1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
11/21/2002	WO2002092594A1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2002	WO2002092593A1 4-(4-pyridazinyl)pyrazole derivatives
11/21/2002	WO2002092590A1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
11/21/2002	WO2002092588A2 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002	WO2002092585A1 Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
11/21/2002	WO2002092576A1 Diarylurea derivatives useful as anti-inflammatory agents

1 ... 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 ... 1564